HURA Stock Analysis: Buy, Sell, or Hold?
HURA - TuHURA Biosciences, Inc. Common Stock
$1.41
-0.21 (-12.96%)
▼
5d:
-27.69%
30d:
-14.02%
90d:
+86.34%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Mar 26, 2026
0d
Get Alerted When HURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HURA is down 27.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HURA is down 27.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HURA is currently trading at $1.41, which is considered oversold relative to its 30-day fair value range of $1.53 to $1.97.
Technical Outlook: Technically, HURA is showing sideways momentum. Immediate support is located at $1.34, while resistance sits at $2.15. Short-term momentum is weak, with the stock down 13.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.62 (+511.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HURA is showing sideways momentum. Immediate support is located at $1.34, while resistance sits at $2.15. Short-term momentum is weak, with the stock down 13.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.62 (+511.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.53 -
$1.97
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-13.0%)
- BULLISH: Trading 511.7% below Wall St target ($8.62)
- WARNING: Recommendation downgraded due to -27.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.53 -
$1.97
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.34
Resistance Level
$2.15
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.24
Wall Street Target
$8.63
(+511.7%)
Share & Embed Analysis
Last updated: April 02, 2026 7:10 PM ET
Data refreshes hourly during market hours. Next update: 8:10 PM
Data refreshes hourly during market hours. Next update: 8:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HURA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 65 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 61 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 50 HOLD |
